Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

9.9%

7 terminated/withdrawn out of 71 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

15%

11 trials in Phase 3/4

Results Transparency

19%

8 of 42 completed trials have results

Key Signals

7 recruiting8 with results6 withdrawn

Enrollment Performance

Analytics

N/A

32(53.3%)

Phase 1

8(13.3%)

Phase 2

8(13.3%)

Phase 4

7(11.7%)

Phase 3

4(6.7%)

Early Phase 1

1(1.7%)

60Total

N/A(32)

Phase 1(8)

Phase 2(8)

Phase 4(7)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (71)

Showing 20 of 71 trials

NCT07645300Phase 2Not Yet Recruiting

LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial

Role: collaborator

NCT04793776Not ApplicableRecruiting

Manage Emotions to Reduce Aggression (MERA)

Role: collaborator

NCT04360681Phase 2Completed

Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans

Role: collaborator

NCT06723743Not ApplicableRecruiting

Transcutaneous Vagus Nerve Stimulation for Attention and Memory

Role: collaborator

NCT04502563Not ApplicableCompleted

LINK-HF2 - Remote Monitoring Analytics in Heart Failure

Role: collaborator

NCT05471011Active Not Recruiting

COVID-19 Outcome Prediction Algorithm

Role: collaborator

NCT04221750Phase 3Completed

Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors

Role: collaborator

NCT06957067Not ApplicableRecruiting

Reducing Dropout and Improving Outcomes From PTSD Therapy: When to Switch Therapies or Stay the Course

Role: collaborator

NCT06529094Not ApplicableRecruiting

Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

Role: collaborator

NCT05563766Phase 2Recruiting

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Role: collaborator

NCT07220161Not ApplicableActive Not Recruiting

Trigeminal Nerve Stimulation of the Treatment of Epilepsy

Role: collaborator

NCT05008198Active Not Recruiting

Assessing an EEG Biomarker of Response to TMS for Major Depression

Role: collaborator

NCT01261065Phase 4Completed

Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure

Role: lead

NCT04306588Phase 1Withdrawn

Accessing Mobility Using Wearable Sensors

Role: collaborator

NCT05220202Not ApplicableRecruiting

MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression

Role: collaborator

NCT05992311Phase 1Recruiting

Clinical Evaluation of Montelukast in Veterans With Gulf War Illness

Role: collaborator

NCT06230887Not ApplicableEnrolling By Invitation

Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study

Role: collaborator

NCT03329963Not ApplicableCompleted

Lifestyle Intervention to Improve Bone Quality

Role: collaborator

NCT03756051Completed

Harms of Hepatocellular Carcinoma Surveillance

Role: collaborator

NCT04166240Not ApplicableCompleted

Measuring and Improving the Safety of Test Result Follow-Up

Role: collaborator